APA (7th ed.) Citation

An, E, L, B., C, D., Á, T., & DP, M. (2015). A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: A post hoc analysis based on the European label recommendation. Dove Medical Press.

Chicago Style (17th ed.) Citation

An, E, Berggren L, Deix C, Tóth Á, and McDonnell DP. A 6-year Open-label Study of the Efficacy and Safety of Olanzapine Long-acting Injection in Patients with Schizophrenia: A Post Hoc Analysis Based on the European Label Recommendation. Dove Medical Press, 2015.

MLA (8th ed.) Citation

An, et al. A 6-year Open-label Study of the Efficacy and Safety of Olanzapine Long-acting Injection in Patients with Schizophrenia: A Post Hoc Analysis Based on the European Label Recommendation. Dove Medical Press, 2015.